The Results of Clinical Trials of Recombinant Vaccine Virus, MVA Strain, Expressing Genes of Human Immunodeficiency Virus
Although successes in antiretroviral therapy (ART) turned AIDS from lethal illness into sluggishly progressing disease, its prevention and treatment remain one of the most socially significant concerns. The increase in the number of patients infected with human immunodeficiency virus (HIV), especial...
Saved in:
Main Authors: | L. F. Stovba, S. A. Mel’nikov, D. I. Paveli’ev, V. T. Krotkov, N. K. Chernikova, V. N. Lebedev, S. V. Borisevich |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe”
2021-10-01
|
Series: | Проблемы особо опасных инфекций |
Subjects: | |
Online Access: | https://journal.microbe.ru/jour/article/view/1543 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis and Prospects of Using Recombinant Vaccinia Virus MVA Strain as a Vector in the Development of the Vaccines against Human and Simian Immunodeficiency Virus Diseases
by: L. F. Stovba, et al.
Published: (2019-07-01) -
Comparison of the Efficacy of Different Schemes for Using Recombinant Vector Vaccines against Ebola Fever, Based on Vaccinia Virus, MVA Strain
by: L. F. Stovba, et al.
Published: (2024-01-01) -
Safety and immunogenicity of IMVAMUNE®, a third-generation vaccine based on the modified vaccinia Ankara (MVA) strain
by: L. F. Stovba, et al.
Published: (2023-04-01) -
Smallpox Vaccine LC16m8: Production, Properties, and Prospects
by: L. F. Stovba, et al.
Published: (2024-10-01) -
ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2
by: Juan García-Arriaza, et al.
Published: (2025-06-01)